Significance of the Superior Vena Caval Syndrome

Bruckner, William J.

doi:10.1001/archinte.1958.00260190090010

Cited by 15 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The distribution of etiologies of superior vena caval obstruction in this study, particularly a malignant to benign ratio of 4.25 to 1, is similar to other studies [3][4][5][6][7]11,13] in the literature reported from general hospital populations. In our experience, the underlying malignant disorder was found to be lymphoma (33%), small cell lung cancer (10%), and non-small cell cancer (24%).…”

Section: Discussionsupporting

confidence: 89%

Superior Vena Caval Obstruction: King Khalid University Hospital Experience

Ajarim

1992

Ann Saudi Med

View full text Add to dashboard Cite

A five year experience, in 21 patients with superior vena caval obstruction (SVCO) was reviewed. SVCO was due to benign conditions in four patients (19%) and malignant tumors in 17 patients (81%). Lymphoma and lung cancer were the most common causes encountered. The most common symptoms and signs were facial swelling, shortness of breath, jugular venous distention, swelling of face and arms, and engorgement of thoracic veins. Benign disorders had a longer duration of symptoms before presentation and required longer time to make the diagnosis than in malignant disorders. No serious complications resulted from the superior vena cava obstruction itself or the investigative procedures leading to the diagnosis. Prognosis and response to treatment were dependent on the underlying cause of SVCO. Chemotherapy was effective in induction of complete regression of SVCO in the majority of patients with underlying malignant disorders. We conclude that SVCO should be approached invasively for diagnosis and tissue diagnosis of the underlying disorder should dictate the appropriate therapy.

show abstract